{"organizations": [], "uuid": "2a4adb2be231ea3fb7ce84cf19f321745cdaccd8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/10/15/idUSFWN12E02F20151015", "country": "US", "title": "BRIEF-Ablynx gets first milestone in immuno-oncology deal with Merck & Co.", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-Ablynx gets first milestone in immuno-oncology deal with Merck & Co. | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-10-15T09:18:00.000+03:00", "replies_count": 0, "uuid": "2a4adb2be231ea3fb7ce84cf19f321745cdaccd8"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/10/15/idUSFWN12E02F20151015", "ord_in_thread": 0, "title": "BRIEF-Ablynx gets first milestone in immuno-oncology deal with Merck & Co.", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Oct 15 Ablynx NV :\n* Achieves first milestone in immuno-oncology collaboration with Merck & Co., Inc.\n* To receive 3.5 million euros ($4.02 million) milestone payment Source text for Eikon: Further company coverage: ($1 = 0.8708 euros) (Gdynia Newsroom)", "external_links": [], "published": "2015-10-15T09:18:00.000+03:00", "crawled": "2015-10-15T08:26:07.148+03:00", "highlightTitle": ""}